info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Seladelpar
505
Article source: Seagull Pharmacy
Oct 09, 2025

Seladelpar is a new-type therapeutic drug for primary biliary cholangitis (PBC), which exerts its effects by activating peroxisome proliferator-activated receptor delta (PPARδ).

Indications for Seladelpar

Main Therapeutic Uses

Seladelpar is approved for the treatment of two categories of adult patients with primary biliary cholangitis (PBC) as follows.

Combination therapy: Used in combination with ursodeoxycholic acid (UDCA), it is indicated for PBC patients with an inadequate response to UDCA.

Monotherapy: Used as monotherapy for PBC patients who cannot tolerate UDCA.

Usage Restrictions and Precautions

It is not recommended for patients with decompensated cirrhosis (e.g., ascites, variceal bleeding, hepatic encephalopathy).

It must be used under the guidance of a physician with experience in PBC treatment.

Regular monitoring of liver function indicators and bone health status is required.

Specifications and Properties of Seladelpar

Preparation Specifications

Seladelpar is an oral hard capsule preparation.

Specification: 10 mg per capsule (calculated as seladelpar free acid).

Appearance Characteristics

The capsules are opaque.

Size: Size 1 capsules.

Color: Opaque light gray capsule body and opaque dark blue capsule cap.

Marking: The capsule cap is printed with "CBAY", and the capsule body is printed with "10".

Composition

Active ingredient: 14.1 mg seladelpar lysine salt (equivalent to 10 mg seladelpar free acid).

Excipients: Butylated hydroxytoluene (BHT), colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, mannitol, microcrystalline cellulose.

Capsule shell: Gelatin, titanium dioxide, iron oxide colorants, and FD&C Blue No. 2.

Storage Method for Seladelpar

Storage Condition Requirements

Temperature: Store at room temperature between 20°C and 25°C (68°F and 77°F).

Allowable fluctuation range: Short-term exposure to temperatures between 15°C and 30°C (59°F and 86°F) is tolerable.

Precautions: Keep in the original packaging to protect from light and avoid humid environments.

Special Handling Requirements

Child protection: Packaged with child-resistant caps; store out of the reach of children.

Moisture and damage prevention: Keep the desiccant inside the bottle intact and avoid crushing or deforming the capsules.

Expired disposal: Expired drugs should be disposed of professionally in accordance with local regulations.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Use Seladelpar
Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-δ agonist, which was approved in the United States in 2024 for the treatment of primary biliary cholangitis (PBC).How to Use Seladelpa...
Precautions for Seladelpar Administration
Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-δ agonist. It is indicated for combination therapy with ursodeoxycholic acid (UDCA) in adult patients who have an inadequate response ...
What Are the Side Effects of Seladelpar?
Seladelpar is a peroxisome proliferator-activated receptor (PPAR)-δ agonist, primarily used for the treatment of adult patients with primary biliary cholangitis (PBC) who have an inadequate response t...
Indications for Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar)
Losartan Potassium and Hydrochlorothiazide Tablets (Hyzaar) is a compound antihypertensive medication composed of losartan potassium (an angiotensin II receptor blocker, ARB) and hydrochlorothiazide (...
How to Purchase Seladelpar
Seladelpar is a novel PPAR-δ agonist, indicated for the treatment of adult patients with primary biliary cholangitis (PBC) who have an inadequate response to ursodeoxycholic acid (UDCA) or cannot tole...
What Are the Side Effects of Opdualag?
Opdualag is a fixed-dose combination medication consisting of nivolumab and relatlimab-rmbw. It is indicated for the treatment of patients aged 12 years and older with unresectable or metastatic melan...
Precautions for Opdualag Administration
Opdualag is a fixed-dose combination preparation of nivolumab and relatlimab-rmbw, indicated for the treatment of patients aged 12 years and older with unresectable or metastatic melanoma.Precautions ...
How to Use Opdualag
Opdualag is a fixed-dose combination preparation composed of nivolumab and relatlimab-rmbw. It is indicated for the treatment of patients aged 12 years and older with unresectable or metastatic melano...
Related Articles
Dosage and Administration, Precautions, and Healthy Lifestyle for Cenobamate
Cenobamate is a novel once-daily oral antiepileptic drug. Correct dosage and administration, strict adherence to precautions, and a healthy lifestyle are critical to ensuring its efficacy and safety.I...
Side Effects of Cenobamate and Management Strategies
Cenobamate is an effective novel antiepileptic drug, but it is associated with a range of side effects.I. Side Effects of Cenobamate1. Most Common Side Effects (Incidence ≥10% and higher than placebo)...
Safinamide (Xadago): Domestic Launch and Purchase Guide in China
As an adjunctive treatment for Parkinson’s disease, the accessibility of safinamide in China is a major concern for patients.I. Domestic Launch Status1. Not Yet Launched in Chinese Mainland(1) As of A...
Analysis of the Therapeutic Value and Accessibility of Safinamide (Xadago)
As an adjunctive treatment for "off" episodes in Parkinson’s disease, safinamide’s clinical efficacy, medical insurance coverage, and pricing are common concerns for patients and their famil...
Dosage and Administration, Precautions, and Healthy Living Guidelines for Anagrelide (Agrylin)
Anagrelide is a prescription platelet-lowering medication that must be used precisely under the guidance of a physician.I. Dosage and Administration1. Adult Starting Dose(1) The recommended starting d...
Anagrelide (Agrylin): Side Effects, Management Strategies and Storage Guidelines
Anagrelide is a platelet-lowering agent with well-established efficacy, yet it is associated with a variety of adverse reactions.I. Common Side Effects1. Adverse Reactions with an Incidence Rate ≥ 5%T...
Drug Overview and Administration Guidance for Topiroxostat
Topiroxostat is a non-purine selective xanthine oxidase inhibitor indicated for the treatment of gout and hyperuricemia.I. Pharmaceutical Properties and Mechanism of Action1. Active Ingredient and Dos...
Key Clinical Application Guidelines for Topiroxostat
Topiroxostat is a non-purine selective xanthine oxidase inhibitor that exerts a uric acid-lowering effect by inhibiting uric acid production.I. Indications and Target Population1. Approved Indications...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved